|27.96||-0.1100||-0.39%||Vol 248.46K||1Y Perf -77.99%|
|Nov 25th, 2022 13:00 DELAYED|
|- -||- -%|
|Target Price||116.43||Analyst Rating||Moderate Buy 2.18|
|Potential %||316.42||Finscreener Ranking||★ 41.85|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||+ 35.34|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 50.89|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||1.44||Earnings Rating||Strong Buy|
|Market Cap||1.66B||Earnings Date||2nd Nov 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.45|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||957.46K|
|Avg. Monthly Volume||1.36M|
|Avg. Quarterly Volume||940.16K|
Rapid7 Inc. (NASDAQ: RPD) stock closed at 27.96 per share at the end of the most recent trading day (a -0.39% change compared to the prior day closing price) with a volume of 248.46K shares and market capitalization of 1.66B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Software industry, Technology sector and employs 1847 people. Rapid7 Inc. CEO is Corey E. Thomas.
The one-year performance of Rapid7 Inc. stock is -77.99%, while year-to-date (YTD) performance is -76.24%. RPD stock has a five-year performance of 46.85%. Its 52-week range is between 26.485 and 129.09, which gives RPD stock a 52-week price range ratio of 1.44%
Rapid7 Inc. currently has a PE ratio of -10.40, a price-to-book (PB) ratio of 57.92, a price-to-sale (PS) ratio of 2.53, a price to cashflow ratio of 38.80, a PEG ratio of 2.32, a ROA of -13.37%, a ROC of -15.98% and a ROE of 136.62%. The company’s profit margin is -23.94%, its EBITDA margin is -15.90%, and its revenue ttm is $652.24 Million , which makes it $11.01 revenue per share.
Of the last four earnings reports from Rapid7 Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.45 for the next earnings report. Rapid7 Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Rapid7 Inc. is Moderate Buy (2.18), with a target price of $116.43, which is +316.42% compared to the current price. The earnings rating for Rapid7 Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Rapid7 Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Rapid7 Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.35, ATR14 : 2.31, CCI20 : -55.67, Chaikin Money Flow : -0.16, MACD : -3.84, Money Flow Index : 47.78, ROC : -3.22, RSI : 35.35, STOCH (14,3) : 25.85, STOCH RSI : 0.51, UO : 47.56, Williams %R : -74.15), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Rapid7 Inc. in the last 12-months were: Andrew F. Burton (Sold 14 558 shares of value $1 684 696 ), Benjamin Holzman (Option Excercise at a value of $102 300), Christina Luconi (Sold 9 229 shares of value $880 811 ), Corey E. Thomas (Option Excercise at a value of $585 800), Corey E. Thomas (Sold 50 000 shares of value $5 000 060 ), Nye Benjamin (Option Excercise at a value of $431 322), Thomas E. Schodorf (Option Excercise at a value of $5 530), Thomas E. Schodorf (Sold 770 shares of value $85 422 )
Fri, 04 Nov 2022 05:53 GMT Analysts Offer Insights on Technology Companies: Rapid7 (RPD) and Coinbase Global (COIN)- TipRanks. All rights reserved.
Thu, 03 Nov 2022 12:36 GMT Rapid7 (RPD) Receives a Buy from Raymond James- TipRanks. All rights reserved.
Mon, 22 Aug 2022 12:06 GMT Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.